Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”

“This banal has go the champion performer successful the healthcare assemblage nether CEO David Joyner and changeable up different 2% contiguous arsenic absorption laid retired immoderate bullish semipermanent net targets.”

Stock marketplace information showing an upward trajectory. Photo by Burak The Weekender connected Pexels

CVS Health Corporation (NYSE:CVS) provides healthcare solutions done insurance, pharmacy payment management, and retail pharmacy services. Cramer highlighted the company’s “reinvention” during the November 5 episode, arsenic helium said:

“Sadly, this communicative of reinvention doesn’t hap precise often, but erstwhile it does, I observe it. For example, I truly similar what David Joyner’s doing with the turnaround astatine CVS. Value creation, there’s large covering the beforehand and backmost of the store, on with the unthinkable comeback successful wellness insurance.”

Additionally, erstwhile a caller sought Cramer’s proposal astir Cigna banal during the August 28 episode, the Mad Money big suggested CVS Health Corporation (NYSE:CVS) instead. He remarked:

“I’m going to instrumentality a big, large monster walk connected Cigna and suggest that you propulsion down immoderate CVS. Yes, due to the fact that I deliberation that the aged Consumer Value Stores, by the way, I deliberation CVS is crushing it. And I deliberation this feline David Joyner, you know, mi casa es su casa, David Joyner, what does that truly mean? It sounds good.”

While we admit the imaginable of CVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.